WCWM
TMO icon

Willow Creek Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Willow Creek Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.11M Sell
4,344
-11
-0.3% -$5.12K 0.17% 51
2025
Q2 		$1.77M Sell
4,355
-1
-0% -$418 0.16% 56
2025
Q1 		$2.17M Buy
4,356
+3
+0.1% +$1.63K 0.21% 46
2024
Q4 		$2.26M Sell
4,353
-7
-0.2% -$3.85K 0.23% 45
2024
Q3 		$2.7M Sell
4,360
-8
-0.2% -$4.74K 0.28% 42
2024
Q2 		$2.42M Buy
4,368
+5
+0.1% +$2.86K 0.27% 43
2024
Q1 		$2.54M Sell
4,363
-10
-0.2% -$5.61K 0.3% 42
2023
Q4 		$2.32M Buy
4,373
+172
+4% +$83.3K 0.29% 42
2023
Q3 		$2.13M Sell
4,201
-9
-0.2% -$4.8K 0.32% 36
2023
Q2 		$2.2M Buy
4,210
+4
+0.1% +$2.16K 0.31% 39
2023
Q1 		$2.42M Sell
4,206
-26
-0.6% -$14.7K 0.37% 35
2022
Q4 		$2.33M Sell
4,232
-21
-0.5% -$11.1K 0.39% 33
2022
Q3 		$2.16M Sell
4,253
-852
-17% -$477K 0.42% 31
2022
Q2 		$2.77M Sell
5,105
-52
-1% -$28.6K 0.51% 26
2022
Q1 		$3.05M Sell
5,157
-2
-0% -$1.15K 0.61% 23
2021
Q4 		$3.44M Sell
5,159
-57
-1% -$35.6K 0.71% 22
2021
Q3 		$2.98M Hold
5,216
– – 0.66% 22
2021
Q2 		$2.63M Buy
5,216
+16
+0.3% +$7.55K 0.63% 22
2021
Q1 		$2.37M Sell
5,200
-74
-1% -$35.3K 0.87% 18
2020
Q4 		$2.46M Sell
5,274
-96
-2% -$45K 0.93% 16
2020
Q3 		$2.37M Sell
5,370
-488
-8% -$202K 0.98% 15
2020
Q2 		$2.12M Hold
5,858
– – 0.95% 14
2020
Q1 		$1.66M Hold
5,858
– – 0.84% 15
2019
Q4 		$1.9M Sell
5,858
-101
-2% -$30.6K 0.87% 14
2019
Q3 		$1.74M Buy
5,959
+17
+0.3% +$4.87K 0.8% 15
2019
Q2 		$1.75M Hold
5,942
– – 0.84% 14
2019
Q1 		$1.63M Hold
5,942
– – 0.82% 14
2018
Q4 		$1.33M Sell
5,942
-85
-1% -$19.9K 0.71% 16
2018
Q3 		$1.47M Sell
6,027
-86
-1% -$19.8K 0.82% 13
2018
Q2 		$1.27M Sell
6,113
-47
-0.8% -$9.98K 0.71% 13
2018
Q1 		$1.27M Buy
+6,160
New +$1.29M 0.68% 16

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Willow Creek Wealth Management's TMO Position: Q3 2025 in Review

Willow Creek Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.25% in Q3 2025, selling an estimated $5.12K and leaving 4,344 shares worth $2.11M. The position accounts for 0.17% of the portfolio, ranked #51.

Willow Creek Wealth Management first reported a position in TMO in Q1 2018 and has held it in 31 quarters since. The position peaked at $3.44M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Willow Creek Wealth Management held 4,344 shares of Thermo Fisher Scientific worth $2.11M as of Q3 2025.
  • Willow Creek Wealth Management sold 11 Thermo Fisher Scientific shares in Q3 2025, an estimated $5.12K.
  • Thermo Fisher Scientific made up 0.17% of Willow Creek Wealth Management's portfolio in Q3 2025, its #51 holding.
  • Willow Creek Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 31 quarters since.
  • Willow Creek Wealth Management's Thermo Fisher Scientific position peaked at $3.44M in Q4 2021.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Willow Creek Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.